您的位置:首页 > 半岛bd体育手机客户端 中心 > 181223-80-3, DEL-22379
DEL-22379
半岛bd体育手机客户端 编号: | 4086696 |
规格: | ≥98% (HPLC) |
CAS NO: | 181223-80-3 |
包装规格: | 5 MG,25 MG |
半岛bd体育手机客户端 类别: | 进口试剂 |
品牌: | Sigma-Aldrich |
优惠价: | 立即咨询 |
半岛bd体育手机客户端 价格
查看更多规格...
半岛bd体育手机客户端 编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
4086696 | 5 MG | 1220 | |||
4086696 | 25 MG | 4490 |
半岛bd体育手机客户端 别名
181223-80-3
DEL-22379
N-[2,3-Dihydro-3-[(5-methoxy-1H-indol-3-yl)methylene]-2-oxo-1H-indol-5-yl]-1-piperidinepropanamide
N-(3-((5-Methoxy-1H-indol-3-yl)methylene)-2-oxoindolin-5-yl)-3-(piperidin-1-yl)propanamide
结构式
基本信息
Empirical Formula【经验(实验)分子式】 |
C
26H
28N
4O
3
|
Molecular weight |
444.53
|
MDL number |
MFCD00950163
|
Biochem/physiol Actions【生化/生理作用】 |
DEL-22379 is a cell-permeable 3-arylidene-2-oxindole derivative that inhibits the dimerization of ERK (IC
50= 500 nM) via directly binding to its dimerization interface. DEL-22379 promotes the transactivation of ELK, and prevents the EGF-induced phosphorylation of the cytoplasmic kinase RSK1 in HEK293 cells (IC
50= 500 nM). DEL-22379 induces apoptosis in various cancer cells harboring RAS-ERK pathway oncogenes (IC
50= 150 – 400 nM). DEL-22379 blocks tumor progression and metastasis in multiple xenograft models such as A375 (BRAF mutant), HCT116 (KRAS mutant) and colorectal cancer patient-derived xenografts (15 mg/kg, i.p. b.i.d.).
|
半岛bd体育手机客户端 性质
Quality Level【质量水平】 |
100
|
Assay【测定】 |
≥98% (HPLC)
|
form【形式】 |
powder
|
color【颜色】 |
white to beige
|
solubility【溶解性】 |
DMSO: 10 mg/mL, clear
|
storage temp.【储存温度】 |
?20℃
|
SMILES string |
O=C1NC2=CC=C(NC(CCN3CCCCC3)=O)C=C2C1=CC4=CNC5=C4C=C(OC)C=C5
|
packaging【包装】 |
5, 25 mg in glass bottle
|
安全信息
Pictograms【象形图】 |
GHS07
|
Signal word【警示用语:】 |
Warning
|
Hazard Statements |
H315 - H319
|
Precautionary Statements |
P305 + P351 + P338
|
Hazard Classifications【危险分类】 |
Eye Irrit. 2 - Skin Irrit. 2
|
Storage Class Code【储存分类代码】 |
13 - Non Combustible Solids
|
WGK |
WGK 3
|